{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:39:39Z","timestamp":1789421979288,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.pntd.0013230","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000}}],"reference-count":135,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["R38 HL155774"],"award-info":[{"award-number":["R38 HL155774"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>The viral hemorrhagic fevers Ebola and Lassa fever are endemic to Sub-Saharan Africa. Both viruses are characterized by high case fatality risk and lifelong debilitating sequelae including blindness and deafness. However, despite these findings the mechanisms of disease and pathogenesis through which these viruses act remain poorly understood. The objective of this systematic review was to synthesize known data regarding both acute and chronic immune-inflammatory dysfunction. A comprehensive search strategy was conducted from July 2022- August 2024. A total of 1,587 articles were identified and evaluated for inclusion. In total 49 Ebola specific and 31 Lassa fever articles were included in this review. The results of this study found considerable dysregulation in immune-inflammatory homeostasis. Specifically, Ebola was found to induce increased concentrations of molecules associated with immune cell recruitment and migration during acute disease. In addition, the virus led to reduction in innate cell populations and expansion of T-cell population frequencies across disease outcomes. Studies of Lassa fever also demonstrated considerable immune dysregulation. However, given the relative lack of studies the exact mechanism of disease is unclear. Among disease survivors, both viruses demonstrate persistent chronic immune dysregulation years following disease onset. However, associating these findings with post-viral syndromes is controversial.<\/jats:p>","DOI":"10.1371\/journal.pntd.0013230","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T14:29:29Z","timestamp":1750861769000},"page":"e0013230","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["A systematic review of the immuno-inflammatory dysfunction secondary to viral hemorrhagic fevers; Ebola and Lassa fever"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4570-201X","authenticated-orcid":true,"given":"Samuel","family":"Ficenec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nell","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Zifodya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Schieffelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"pntd.0013230.ref001","author":"COVID-19 deaths | WHO COVID-19 dashboard"},{"issue":"1","key":"pntd.0013230.ref002","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1038\/s41467-023-43661-w","article-title":"True prevalence of long-COVID in a nationwide, population cohort study","volume":"14","author":"CE Hastie","year":"2023","journal-title":"Nat Commun"},{"key":"pntd.0013230.ref003","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86002","article-title":"Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)","volume":"12","author":"ZA Sherif","year":"2023","journal-title":"Elife"},{"issue":"8","key":"pntd.0013230.ref004","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3390\/cells10082134","article-title":"Implications of Innate Immunity in Post-Acute Sequelae of Non-Persistent Viral Infections","volume":"10","author":"M Hirschenberger","year":"2021","journal-title":"Cells"},{"issue":"1","key":"pntd.0013230.ref005","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1186\/s12879-022-07604-y","article-title":"The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone","volume":"22","author":"SC Ficenec","year":"2022","journal-title":"BMC Infect Dis"},{"issue":"6","key":"pntd.0013230.ref006","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/cid\/ciab267","article-title":"Post-Ebola Syndrome Presents With Multiple Overlapping Symptom Clusters: Evidence From an Ongoing Cohort Study in Eastern Sierra Leone","volume":"73","author":"NG Bond","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"16","key":"pntd.0013230.ref007","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.1990.03450160063030","article-title":"Acute Sensorineural Deafness in Lassa Fever","volume":"264","author":"D Cummins","year":"1990","journal-title":"JAMA"},{"key":"pntd.0013230.ref008","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijid.2020.08.021","article-title":"Lassa Fever Induced Hearing Loss: The Neglected Disability of Hemorrhagic Fever","volume":"100","author":"SC Ficenec","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"1","key":"pntd.0013230.ref009","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.32216","article-title":"Characterization of Ebola Virus-Associated Eye Disease","volume":"4","author":"AO Eghrari","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"12","key":"pntd.0013230.ref010","article-title":"Ophthalmic manifestations and vision impairment in Lassa fever survivors","volume":"15","author":"AL Li","year":"2020","journal-title":"PLoS One"},{"key":"pntd.0013230.ref011","doi-asserted-by":"crossref","first-page":"1909410","DOI":"10.1155\/2018\/1909410","article-title":"Post-Ebola Syndrome among Ebola Virus Disease Survivors in Montserrado County, Liberia 2016","volume":"2018","author":"HW Wilson","year":"2018","journal-title":"Biomed Res Int"},{"issue":"7","key":"pntd.0013230.ref012","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/cid\/civ453","article-title":"Study of Ebola Virus Disease Survivors in Guinea","volume":"61","author":"AI Qureshi","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10","key":"pntd.0013230.ref013","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.3390\/v4102031","article-title":"Pathogenesis of Lassa fever","volume":"4","author":"NE Yun","year":"2012","journal-title":"Viruses"},{"issue":"1","key":"pntd.0013230.ref014","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1286-4579(01)01508-8","article-title":"Monitoring of clinical and laboratory data in two cases of imported Lassa fever","volume":"4","author":"H Schmitz","year":"2002","journal-title":"Microbes Infect"},{"issue":"12","key":"pntd.0013230.ref015","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1086\/320722","article-title":"Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever","volume":"183","author":"S Mahanty","year":"2001","journal-title":"J Infect Dis"},{"issue":"4","key":"pntd.0013230.ref016","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/(SICI)1096-9071(199912)59:4<552::AID-JMV21>3.0.CO;2-A","article-title":"Lassa and mopeia virus replication in human monocytes\/macrophages and in endothelial cells: Different effects on IL-8 and TNF-? gene expression","volume":"59","author":"IS Lukashevich","year":"1999","journal-title":"J Med Virol"},{"issue":"5","key":"pntd.0013230.ref017","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1189\/jlb.4RI0316-099RR","article-title":"Molecular mechanisms of Ebola pathogenesis","volume":"100","author":"A Rivera","year":"2016","journal-title":"J Leukoc Biol"},{"issue":"1","key":"pntd.0013230.ref018","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virol.2007.02.017","article-title":"Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro","volume":"364","author":"M Gupta","year":"2007","journal-title":"Virology"},{"issue":"2","key":"pntd.0013230.ref019","first-page":"140","article-title":"Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure","volume":"120","author":"NK Jaax","year":"1996","journal-title":"Arch Pathol Lab Med"},{"key":"pntd.0013230.ref020","article-title":"Lymphocyte death in a mouse model of Ebola virus infection","author":"SB Bradfute","year":"2007","journal-title":"J Infect Dis"},{"issue":"1","key":"pntd.0013230.ref021","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1038\/s41467-020-17489-7","article-title":"Long-lasting severe immune dysfunction in Ebola virus disease survivors","volume":"11","author":"A Wiedemann","year":"2020","journal-title":"Nat Commun"},{"issue":"10","key":"pntd.0013230.ref022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000837","article-title":"Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis","volume":"4","author":"N Wauquier","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0013230.ref023","article-title":"Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection","author":"F Villinger","year":"1999","journal-title":"J Infect Dis"},{"issue":"7","key":"pntd.0013230.ref024","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/cid\/ciz1062","article-title":"Long-term Complications of Ebola Virus Disease: Prevalence and Predictors of Major Symptoms and the Role of Inflammation","volume":"71","author":"S Tozay","year":"2020","journal-title":"Clin Infect Dis"},{"key":"pntd.0013230.ref025","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiy352","article-title":"T-Cell Receptor Diversity and the Control of T-Cell Homeostasis Mark Ebola Virus Disease Survival in Humans","volume":"218","author":"E Speranza","year":"2018","journal-title":"J Infect Dis"},{"issue":"1","key":"pntd.0013230.ref026","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/v7010037","article-title":"Immune memory to Sudan virus: comparison between two separate disease outbreaks","volume":"7","author":"A Sobarzo","year":"2015","journal-title":"Viruses"},{"issue":"19","key":"pntd.0013230.ref027","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.1128\/JVI.78.19.10370-10377.2004","article-title":"Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels","volume":"78","author":"A Sanchez","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"pntd.0013230.ref028","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125106","article-title":"Immune parameters and outcomes during Ebola virus disease","volume":"4","author":"S Reynard","year":"2019","journal-title":"JCI Insight"},{"issue":"12","key":"pntd.0013230.ref029","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/rheumatology\/kex074","article-title":"Characteristics of the musculoskeletal symptoms observed among survivors of Ebola virus disease in the Postebogui cohort in Guinea","volume":"56","author":"Y-M Pers","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"pntd.0013230.ref030","doi-asserted-by":"crossref","first-page":"682120","DOI":"10.3389\/fimmu.2021.682120","article-title":"Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors","volume":"12","author":"D Paquin-Proulx","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"pntd.0013230.ref031","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4269\/ajtmh.15-0461","article-title":"A Health Care Worker with Ebola Virus Disease and Adverse Prognostic Factors Treated in Sierra Leone","volume":"94","author":"MK O\u2019Shea","year":"2016","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"pntd.0013230.ref032","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3201\/eid2502.181326","article-title":"Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1","volume":"25","author":"AK McElroy","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"pntd.0013230.ref033","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/cid\/ciw334","article-title":"Kinetic Analysis of Biomarkers in a Cohort of US Patients With Ebola Virus Disease","volume":"63","author":"AK McElroy","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"9222","key":"pntd.0013230.ref034","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/S0140-6736(00)02405-3","article-title":"Human asymptomatic Ebola infection and strong inflammatory response","volume":"355","author":"EM Leroy","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"pntd.0013230.ref035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2249.2001.01517.x","article-title":"Early immune responses accompanying human asymptomatic Ebola infections","volume":"124","author":"EM Leroy","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"pntd.0013230.ref036","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/infdis\/jiaa268","article-title":"Ebola-Specific CD8+ and CD4+ T-Cell Responses in Sierra Leonean Ebola Virus Survivors With or Without Post-Ebola Sequelae","volume":"222","author":"SM LaVergne","year":"2020","journal-title":"J Infect Dis"},{"key":"pntd.0013230.ref037","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiy429","article-title":"Kinetics of Soluble Mediators of the Host Response in Ebola Virus Disease","volume":"218","author":"R Kerber","year":"2018","journal-title":"J Infect Dis"},{"issue":"7","key":"pntd.0013230.ref038","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/infdis\/jix061","article-title":"Features of Ebola Virus Disease at the Late Outbreak Stage in Sierra Leone: Clinical, Virological, Immunological, and Evolutionary Analyses","volume":"215","author":"T Jiang","year":"2017","journal-title":"J Infect Dis"},{"key":"pntd.0013230.ref039","article-title":"Cytokine and chemokine expression in humans infected with Sudan Ebola virus","author":"KL Hutchinson","year":"2007","journal-title":"J Infect Dis"},{"issue":"2","key":"pntd.0013230.ref040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virol.2011.11.027","article-title":"Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus","volume":"423","author":"M Gupta","year":"2012","journal-title":"Virology"},{"issue":"6","key":"pntd.0013230.ref041","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2017.10.011","article-title":"Multi-platform \u2019Omics Analysis of Human Ebola Virus Disease Pathogenesis","volume":"22","author":"AJ Eisfeld","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"4","key":"pntd.0013230.ref042","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/v11040373","article-title":"Inflammatory and Humoral Immune Response during Ebola Virus Infection in Survivor and Fatal Cases Occurred in Sierra Leone during the 2014\u207b2016 Outbreak in West Africa","volume":"11","author":"F Colavita","year":"2019","journal-title":"Viruses"},{"issue":"1","key":"pntd.0013230.ref043","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2249.2002.01800.x","article-title":"Inflammatory responses in Ebola virus-infected patients","volume":"128","author":"S Baize","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"pntd.0013230.ref044","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"S Baize","year":"1999","journal-title":"Nat Med"},{"issue":"5","key":"pntd.0013230.ref045","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1128\/JVI.74.5.2186-2192.2000","article-title":"Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein","volume":"74","author":"J ter Meulen","year":"2000","journal-title":"J Virol"},{"issue":"10","key":"pntd.0013230.ref046","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137260","article-title":"Immunologic timeline of Ebola virus disease and recovery in humans","volume":"5","author":"AK McElroy","year":"2020","journal-title":"JCI Insight"},{"issue":"15","key":"pntd.0013230.ref047","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1073\/pnas.1502619112","article-title":"Human Ebola virus infection results in substantial immune activation","volume":"112","author":"AK McElroy","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"pntd.0013230.ref048","first-page":"287","article-title":"Comprehensive Characterization of Cellular Immune Responses Following Ebola Virus Infection","volume":"215","author":"C Dahlke","year":"2017","journal-title":"J Infect Dis"},{"issue":"5","key":"pntd.0013230.ref049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005645","article-title":"Different features of V\u03b42 T and NK cells in fatal and non-fatal human Ebola infections","volume":"11","author":"E Cimini","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0013230.ref050","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.55","article-title":"Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection","volume":"7","author":"C Agrati","year":"2016","journal-title":"Cell Death Dis"},{"issue":"7601","key":"pntd.0013230.ref051","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature17949","article-title":"Unique human immune signature of Ebola virus disease in Guinea","volume":"533","author":"P Ruibal","year":"2016","journal-title":"Nature"},{"issue":"8","key":"pntd.0013230.ref052","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01439-18","article-title":"Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection","volume":"93","author":"LE Williamson","year":"2019","journal-title":"J Virol"},{"issue":"4","key":"pntd.0013230.ref053","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(20)30736-2","article-title":"Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study","volume":"21","author":"R Thom","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"pntd.0013230.ref054","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ebiom.2019.07.021","article-title":"Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors","volume":"46","author":"A Sobarzo","year":"2019","journal-title":"EBioMedicine"},{"issue":"5","key":"pntd.0013230.ref055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/v8050133","article-title":"Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus Survivors","volume":"8","author":"A Sobarzo","year":"2016","journal-title":"Viruses"},{"issue":"11","key":"pntd.0013230.ref056","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1128\/CVI.00363-12","article-title":"Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay","volume":"19","author":"A Sobarzo","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"pntd.0013230.ref057","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/infdis\/jit162","article-title":"Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu)","volume":"208","author":"A Sobarzo","year":"2013","journal-title":"J Infect Dis"},{"issue":"9","key":"pntd.0013230.ref058","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/v12090915","article-title":"Ebola Virus Disease Survivors Show More Efficient Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins","volume":"12","author":"T Koch","year":"2020","journal-title":"Viruses"},{"issue":"2","key":"pntd.0013230.ref059","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2020.01.001","article-title":"Longitudinal Human Antibody Repertoire against Complete Viral Proteome from Ebola Virus Survivor Reveals Protective Sites for Vaccine Design","volume":"27","author":"S Khurana","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"5","key":"pntd.0013230.ref060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006530","article-title":"A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals","volume":"12","author":"BB Herrera","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"pntd.0013230.ref061","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007654","article-title":"Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study","volume":"13","author":"PJ Halfmann","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0013230.ref062","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/infdis\/jiz364","article-title":"Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses","volume":"221","author":"BM Gunn","year":"2020","journal-title":"J Infect Dis"},{"issue":"5","key":"pntd.0013230.ref063","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/trf.15739","article-title":"Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States","volume":"60","author":"CL Dean","year":"2020","journal-title":"Transfusion"},{"issue":"6","key":"pntd.0013230.ref064","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.04.036","article-title":"Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection","volume":"177","author":"CW Davis","year":"2019","journal-title":"Cell"},{"issue":"2","key":"pntd.0013230.ref065","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/9bc62f9e-8386-4e9b-951c-1eeba930a41c","article-title":"High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon","volume":"5","author":"P Becquart","year":"2010","journal-title":"PLoS One"},{"issue":"6277","key":"pntd.0013230.ref066","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.aad5788","article-title":"Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak","volume":"351","author":"ZA Bornholdt","year":"2016","journal-title":"Science"},{"issue":"12","key":"pntd.0013230.ref067","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/infdis\/jiy453","article-title":"Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors","volume":"218","author":"MS Bramble","year":"2018","journal-title":"J Infect Dis"},{"issue":"1","key":"pntd.0013230.ref068","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41467-021-21411-0","article-title":"Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013-16 West Africa epidemic","volume":"12","author":"TRW Tipton","year":"2021","journal-title":"Nat Commun"},{"issue":"32","key":"pntd.0013230.ref069","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1806200115","article-title":"Analysis of CD8+ T cell response during the 2013-2016 Ebola epidemic in West Africa","volume":"115","author":"S Sakabe","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"pntd.0013230.ref070","article-title":"Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers","volume":"11","author":"TV Gale","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0013230.ref071","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/1743-422X-8-404","article-title":"Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report","volume":"8","author":"LM Branco","year":"2011","journal-title":"Virol J"},{"issue":"6","key":"pntd.0013230.ref072","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S1473-3099(20)30737-4","article-title":"Factors associated with progression to death in patients with Lassa fever in Nigeria: an observational study","volume":"21","author":"J Strampe","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"pntd.0013230.ref073","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/1743-422X-8-478","article-title":"Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection","volume":"8","author":"LM Branco","year":"2011","journal-title":"Virol J"},{"issue":"11","key":"pntd.0013230.ref074","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.3201\/eid2611.191694","article-title":"Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever","volume":"26","author":"LE Horton","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"pntd.0013230.ref075","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/155.3.456","article-title":"Clinical virology of Lassa fever in hospitalized patients","volume":"155","author":"KM Johnson","year":"1987","journal-title":"J Infect Dis"},{"issue":"21","key":"pntd.0013230.ref076","article-title":"Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues","volume":"94","author":"JR Port","year":"2020","journal-title":"J Virol"},{"issue":"2","key":"pntd.0013230.ref077","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4269\/ajtmh.12-0466","article-title":"A historical look at the first reported cases of Lassa fever: IgG antibodies 40 years after acute infection","volume":"88","author":"N Bond","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pntd.0013230.ref078","first-page":"811","article-title":"A serological survey of Lassa fever in Liberia","volume":"56","author":"A Bloch","year":"1978","journal-title":"Bull World Health Organ"},{"issue":"4","key":"pntd.0013230.ref079","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/15303660160025903","article-title":"Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations","volume":"1","author":"DG Bausch","year":"2001","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"5","key":"pntd.0013230.ref080","first-page":"465","article-title":"Detection of anti-Lassa antibodies in the Western Forest area of the Ivory Coast","volume":"66","author":"C Akoua-Koffi","year":"2006","journal-title":"Med Trop (Mars)"},{"issue":"5","key":"pntd.0013230.ref081","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/0035-9203(84)90232-3","article-title":"Endemic Lassa fever in Liberia. II. Serological and virological findings in hospital patients","volume":"78","author":"JD Frame","year":"1984","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0013230.ref082","first-page":"605","article-title":"Use of the complement fixation (CF) test in Lassa fever surveillance. Evidence for persistent CF antibodies","volume":"52","author":"A Fabiyi","year":"1975","journal-title":"Bull World Health Organ"},{"issue":"8423","key":"pntd.0013230.ref083","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0140-6736(85)91029-3","article-title":"Early diagnosis of human Lassa fever by ELISA detection of antigen and antibody","volume":"1","author":"PB Jahrling","year":"1985","journal-title":"Lancet"},{"issue":"3","key":"pntd.0013230.ref084","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0035-9203(85)90388-8","article-title":"Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization","volume":"79","author":"PB Jahrling","year":"1985","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0013230.ref085","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1743-422X-8-314","article-title":"Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report","volume":"8","author":"JN Grove","year":"2011","journal-title":"Virol J"},{"issue":"2","key":"pntd.0013230.ref086","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010938","article-title":"Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study","volume":"17","author":"DS Grant","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"pntd.0013230.ref087","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/ice.2019.349","article-title":"Serosurvey on healthcare personnel caring for patients with Ebola virus disease and Lassa virus in the United States","volume":"41","author":"CS Kraft","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"pntd.0013230.ref088","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3201\/eid1205.050052","article-title":"Historical Lassa fever reports and 30-year clinical update","volume":"12","author":"AM Macher","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"pntd.0013230.ref089","doi-asserted-by":"crossref","first-page":"11544","DOI":"10.1038\/ncomms11544","article-title":"Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits","volume":"7","author":"JE Robinson","year":"2016","journal-title":"Nat Commun"},{"issue":"3","key":"pntd.0013230.ref090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002748","article-title":"Lassa fever in post-conflict sierra leone","volume":"8","author":"JG Shaffer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0013230.ref091","doi-asserted-by":"crossref","first-page":"152076","DOI":"10.1016\/j.imbio.2021.152076","article-title":"Immunological screening of Lassa Virus among Health workers and Contacts of patients of Lassa fever in Ondo State","volume":"226","author":"JO Shaibu","year":"2021","journal-title":"Immunobiology"},{"issue":"1","key":"pntd.0013230.ref092","doi-asserted-by":"crossref","first-page":"22330","DOI":"10.1038\/s41598-022-26045-w","article-title":"Humoral and cellular immune responses to Lassa fever virus in Lassa fever survivors and their exposed contacts in Southern Nigeria","volume":"12","author":"C Ugwu","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"pntd.0013230.ref093","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0035-9203(86)90147-1","article-title":"Lassa fever in children in Sierra Leone, West Africa","volume":"80","author":"PA Webb","year":"1986","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"pntd.0013230.ref094","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/0035-9203(84)90013-0","article-title":"Endemic Lassa fever in Liberia. VI. Village serological surveys for evidence of Lassa virus activity in Lofa County, Liberia","volume":"78","author":"JE Yalley-Ogunro","year":"1984","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"11","key":"pntd.0013230.ref095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010882","article-title":"Expansion of CD8+ T cell population in Lassa virus survivors with low T cell precursor frequency reveals durable immune response in most survivors","volume":"16","author":"SM LaVergne","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"pntd.0013230.ref096","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00153-20","article-title":"Identification of Common CD8+ T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone","volume":"94","author":"S Sakabe","year":"2020","journal-title":"J Virol"},{"issue":"3","key":"pntd.0013230.ref097","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008352","article-title":"High crossreactivity of human T cell responses between Lassa virus lineages","volume":"16","author":"BM Sullivan","year":"2020","journal-title":"PLoS Pathog"},{"issue":"8","key":"pntd.0013230.ref098","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/cdd.2015.67","article-title":"Molecular mechanisms of Ebola virus pathogenesis: focus on cell death","volume":"22","author":"L Falasca","year":"2015","journal-title":"Cell Death Differ"},{"key":"pntd.0013230.ref099","doi-asserted-by":"crossref","first-page":"594813","DOI":"10.3389\/fimmu.2020.594813","article-title":"Direct Infection of B Cells by Dengue Virus Modulates B Cell Responses in a Cambodian Pediatric Cohort","volume":"11","author":"V Upasani","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"pntd.0013230.ref100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037334","article-title":"Granulocyte colony-stimulating factor protects mice during respiratory virus infections","volume":"7","author":"T Hermesh","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"pntd.0013230.ref101","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40560-021-00550-y","article-title":"Interleukin-9 promotes intestinal barrier injury of sepsis: a translational research","volume":"9","author":"J-K Sun","year":"2021","journal-title":"J Intensive Care"},{"issue":"3","key":"pntd.0013230.ref102","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1164\/rccm.201201-0134OC","article-title":"Interleukin 5 is protective during sepsis in an eosinophil-independent manner","volume":"186","author":"SN Linch","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"pntd.0013230.ref103","doi-asserted-by":"crossref","first-page":"1242860","DOI":"10.3389\/fimmu.2023.1242860","article-title":"Mechanism underlying polyvalent IgG-induced regulatory T cell activation and its clinical application: Anti-idiotypic regulatory T cell theory for immune tolerance","volume":"14","author":"JR Victor","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"pntd.0013230.ref104","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"TW Geisbert","year":"2003","journal-title":"Am J Pathol"},{"issue":"11","key":"pntd.0013230.ref105","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1086\/379199","article-title":"Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation","volume":"188","author":"CM Bosio","year":"2003","journal-title":"J Infect Dis"},{"issue":"7","key":"pntd.0013230.ref106","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2098","article-title":"How Ebola and Marburg viruses battle the immune system","volume":"7","author":"M Mohamadzadeh","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"22","key":"pntd.0013230.ref107","doi-asserted-by":"crossref","first-page":"12289","DOI":"10.1073\/pnas.220398297","article-title":"The Ebola virus VP35 protein functions as a type I IFN antagonist","volume":"97","author":"CF Basler","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"pntd.0013230.ref108","doi-asserted-by":"crossref","first-page":"8993","DOI":"10.1128\/JVI.00523-09","article-title":"Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain","volume":"83","author":"M Sch\u00fcmann","year":"2009","journal-title":"J Virol"},{"issue":"24","key":"pntd.0013230.ref109","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1128\/JVI.01097-07","article-title":"Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1","volume":"81","author":"SP Reid","year":"2007","journal-title":"J Virol"},{"key":"pntd.0013230.ref110","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1099\/vir.0.017343-0","article-title":"The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide","volume":"91","author":"H Jin","year":"2010","journal-title":"J Gen Virol"},{"issue":"8","key":"pntd.0013230.ref111","doi-asserted-by":"crossref","first-page":"107323","DOI":"10.1016\/j.isci.2023.107323","article-title":"Ebola virus shed glycoprotein is toxic to human T, B, and natural killer lymphocytes","volume":"26","author":"LJ Perez-Valencia","year":"2023","journal-title":"iScience"},{"issue":"1","key":"pntd.0013230.ref112","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/vaccines7010022","article-title":"Role of Type I Interferons on Filovirus Pathogenesis","volume":"7","author":"B Escudero-P\u00e9rez","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"pntd.0013230.ref113","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/viro.2001.0836","article-title":"Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro","volume":"284","author":"M Gupta","year":"2001","journal-title":"Virology"},{"issue":"10","key":"pntd.0013230.ref114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001359","article-title":"Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression","volume":"5","author":"V Wahl-Jensen","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"pntd.0013230.ref115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004509","article-title":"Shed GP of Ebola virus triggers immune activation and increased vascular permeability","volume":"10","author":"B Escudero-P\u00e9rez","year":"2014","journal-title":"PLoS Pathog"},{"key":"pntd.0013230.ref116","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The Pathogenesis of Ebola Virus Disease","volume":"12","author":"L Baseler","year":"2017","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"pntd.0013230.ref117","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.20032141","article-title":"Role of natural killer cells in innate protection against lethal ebola virus infection","volume":"200","author":"KL Warfield","year":"2004","journal-title":"J Exp Med"},{"issue":"5353","key":"pntd.0013230.ref118","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1126\/science.279.5353.1034","article-title":"Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins","volume":"279","author":"Z Yang","year":"1998","journal-title":"Science"},{"issue":"3","key":"pntd.0013230.ref119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000836","article-title":"T cell-dependence of Lassa fever pathogenesis","volume":"6","author":"L Flatz","year":"2010","journal-title":"PLoS Pathog"},{"issue":"2","key":"pntd.0013230.ref120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41579-022-00789-8","article-title":"Lassa fever - the road ahead","volume":"21","author":"RF Garry","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"pntd.0013230.ref121","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijid.2020.11.006","article-title":"Acute kidney injury and mortality in pediatric Lassa fever versus question of access to dialysis","volume":"103","author":"AE Adetunji","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"2","key":"pntd.0013230.ref122","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00134-020-05949-z","article-title":"Treatment of Ebola-related critical illness","volume":"46","author":"P Kiiza","year":"2020","journal-title":"Intensive Care Med"},{"issue":"4","key":"pntd.0013230.ref123","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3390\/microorganisms9040772","article-title":"Lassa virus treatment options","volume":"9","author":"F Hansen","year":"2021","journal-title":"Microorganisms"},{"key":"pntd.0013230.ref124","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.coviro.2019.07.009","article-title":"Lassa fever: With 50 years of study, hundreds of thousands of patients and an extremely high disease burden, what have we learned?","volume":"37","author":"LE Garnett","year":"2019","journal-title":"Curr Opin Virol"},{"issue":"2","key":"pntd.0013230.ref125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/jgid.jgid_20_17","article-title":"Reflections on the Ebola Public Health Emergency of International Concern, Part 1: Post-Ebola Syndrome: The Silent Outbreak","volume":"9","author":"SP Stawicki","year":"2017","journal-title":"J Glob Infect Dis"},{"key":"pntd.0013230.ref126","first-page":"1","article-title":"Post-Ebolavirus disease syndrome: What do we know?","author":"FJ Carod-Artal","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"5","key":"pntd.0013230.ref127","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01896-18","article-title":"Immune-Mediated Systemic Vasculitis as the Proposed Cause of Sudden-Onset Sensorineural Hearing Loss following Lassa Virus Exposure in Cynomolgus Macaques","volume":"9","author":"KA Cashman","year":"2018","journal-title":"mBio"},{"issue":"6","key":"pntd.0013230.ref128","doi-asserted-by":"crossref","first-page":"109518","DOI":"10.1016\/j.celrep.2021.109518","article-title":"Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms","volume":"36","author":"MJ Peluso","year":"2021","journal-title":"Cell Rep"},{"key":"pntd.0013230.ref129","article-title":"T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVID","author":"L Visvabharathy","year":"2022","journal-title":"medRxiv"},{"key":"pntd.0013230.ref130","doi-asserted-by":"crossref","first-page":"155434","DOI":"10.1016\/j.cyto.2021.155434","article-title":"Longitudinal plasma cytokine concentrations and recurrent wheezing after RSV bronchiolitis","volume":"140","author":"R Rodr\u00edguez-Fern\u00e1ndez","year":"2021","journal-title":"Cytokine"},{"issue":"2","key":"pntd.0013230.ref131","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-2249.2003.02062.x","article-title":"Respiratory syncytial virus infection suppresses IFN-gamma production of gammadelta T cells","volume":"131","author":"M Aoyagi","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"pntd.0013230.ref132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157055","article-title":"Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection","volume":"11","author":"SC Burke Schinkel","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"pntd.0013230.ref133","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/01.aids.0000168970.80551.3d","article-title":"Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection","volume":"19","author":"CS Graham","year":"2005","journal-title":"AIDS"},{"key":"pntd.0013230.ref134","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbi.2019.04.040","article-title":"Clinical symptoms and markers of disease mechanisms in adolescent chronic fatigue following Epstein-Barr virus infection: An exploratory cross-sectional study","volume":"80","author":"MS Kristiansen","year":"2019","journal-title":"Brain Behav Immun"},{"key":"pntd.0013230.ref135","doi-asserted-by":"crossref","first-page":"715102","DOI":"10.3389\/fimmu.2021.715102","article-title":"Lasting Immunological Imprint of Primary Epstein-Barr Virus Infection With Associations to Chronic Low-Grade Inflammation and Fatigue","volume":"12","author":"B Fevang","year":"2021","journal-title":"Front Immunol"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0013230","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T17:53:53Z","timestamp":1752083633000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0013230"}},"subtitle":[],"editor":[{"given":"Gregory","family":"Gromowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":135,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0013230","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0013230","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]}}}